These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12821744)

  • 1. Clinical aspects of MuSK antibody positive seronegative MG.
    Sanders DB; El-Salem K; Massey JM; McConville J; Vincent A
    Neurology; 2003 Jun; 60(12):1978-80. PubMed ID: 12821744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ["Seronegative" myasthenia gravis and antiMuSK positive antibodies: description of Spanish series].
    Illa I; Díaz-Manera JA; Juárez C; Rojas-García R; Molina-Porcel L; Aleu A; Pradas J; Gallardo E
    Med Clin (Barc); 2005 Jun; 125(3):100-2. PubMed ID: 15989843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance plasma exchange treatment for muscle specific kinase antibody positive myasthenia gravis patients.
    Yamada C; Teener JW; Davenport RD; Cooling L
    J Clin Apher; 2015 Oct; 30(5):314-9. PubMed ID: 25557356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MuSK-positive myasthenia gravis is rare in the Polish population.
    Kostera-Pruszczyk A; Kamińska A; Dutkiewicz M; Emeryk-Szajewska B; Strugalska-Cynowska MH; Vincent A; Kwieciński H
    Eur J Neurol; 2008 Jul; 15(7):720-4. PubMed ID: 18494794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MuSK antibody-positive, seronegative myasthenia gravis in Korea.
    Lee JY; Sung JJ; Cho JY; Oh DH; Kim HJ; Park JH; Lee KW; Choi YC; Vincent A
    J Clin Neurosci; 2006 Apr; 13(3):353-5. PubMed ID: 16546389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is "seronegative" MG explained by autoantibodies to MuSK?
    Lindstrom J
    Neurology; 2004 Jun; 62(11):1920-1. PubMed ID: 15184587
    [No Abstract]   [Full Text] [Related]  

  • 9. MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG.
    Ohta K; Shigemoto K; Kubo S; Maruyama N; Abe Y; Ueda N; Ohta M
    Neurology; 2004 Jun; 62(11):2132-3. PubMed ID: 15184636
    [No Abstract]   [Full Text] [Related]  

  • 10. [Seronegative myasthenia gravis].
    Gajdos P
    Rev Neurol (Paris); 2004 Feb; 160(2):159-62. PubMed ID: 15034472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.
    Rivner MH; Pasnoor M; Dimachkie MM; Barohn RJ; Mei L
    Neurol Clin; 2018 May; 36(2):293-310. PubMed ID: 29655451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle-specific receptor tyrosine kinase antibody-positive and seronegative myasthenia gravis.
    Muppidi S; Wolfe GI
    Front Neurol Neurosci; 2009; 26():109-119. PubMed ID: 19349708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MuSK-antibody-positive myasthenia gravis in a South Asian population.
    Chang T; Gunaratne P; Gamage R; Riffsy MT; Vincent A
    J Neurol Sci; 2009 Sep; 284(1-2):33-5. PubMed ID: 19394052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience.
    Pasnoor M; Wolfe GI; Nations S; Trivedi J; Barohn RJ; Herbelin L; McVey A; Dimachkie M; Kissel J; Walsh R; Amato A; Mozaffar T; Hungs M; Chui L; Goldstein J; Novella S; Burns T; Phillips L; Claussen G; Young A; Bertorini T; Oh S
    Muscle Nerve; 2010 Mar; 41(3):370-4. PubMed ID: 19882635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
    Saulat B; Maertens P; Hamilton WJ; Bassam BA
    Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase.
    Evoli A; Padua L
    Autoimmun Rev; 2013 Jul; 12(9):931-5. PubMed ID: 23535158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The features of myasthenia gravis with autoantibodies to MuSK.
    Lavrnic D; Losen M; Vujic A; De Baets M; Hajdukovic LJ; Stojanovic V; Trikic R; Djukic P; Apostolski S
    J Neurol Neurosurg Psychiatry; 2005 Aug; 76(8):1099-102. PubMed ID: 16024887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AChR-and MuSK-positive myasthenia gravis: Double trouble.
    Zouvelou V; Psimenou E
    J Neuroimmunol; 2020 Nov; 348():577364. PubMed ID: 32916523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
    Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.